发明名称 |
METHODS AND PHARMACEUTICAL COMPOSITIONS EMPLOYING DESMETHYLSELEGILINE |
摘要 |
Methods and pharmaceutical compositions for using the selegiline metabolite desmethylselegiline and stereoisomeric forms thereof. In particular, the present invention provides novel compositions and methods for using desmethylselegiline, and/or ent-desmethylselegiline, for selegiline-responsive diseases and conditions. Diseases and conditions responsive to selegiline include those produced by neuronal degeneration or neural trauma and those due to immune system dysfunction. Desmethylselegiline, and/or entdesmethylselegiline, is either administered orally or by a route of administration which does not rely upon gastrointestinal absorption. Desmethylselegiline is the R-(-) enantiomer of N-methyl-N-(prop-2-ynyl)-2-aminophenylpropane and ent-desmethylselegiline is the S(+) enantiomer. Claimed compositions include both the R-(-) and S-(+) isomers as well as mixtures thereof. Pharmaceutically acceptable acid addition salts may also be used. Effective dosages are a daily dose of at least about 0.0015 mg/kg of body weight.
|
申请公布号 |
CA2209892(A1) |
申请公布日期 |
1996.07.25 |
申请号 |
CA19962209892 |
申请日期 |
1996.01.11 |
申请人 |
SOMERSET PHARMACEUTICALS, INC. |
发明人 |
DISANTO, ANTHONY R.;BLUME, CHERYL D. |
分类号 |
A61K31/137;(IPC1-7):A61K31/135 |
主分类号 |
A61K31/137 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|